COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome

A significant portion of the U.S. population may experience vaccine hesitancy of a new COVID-19 vaccine. This poses dangers to both the individual and...

Efforts towards a COVID-19 vaccine

The development of a vaccine against SARS coronavirus 2 (SARS-CoV-2) will be the way to restore normality to civil life in this time of a devastating...

COVID-19 vaccine development: What lessons can we learn from TB?

The SARS-CoV-2 virus has infected more than 49 million people causing more than 1.2 million deaths worldwide since its emergence from Wuhan, China in...

Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development

The Coronavirus disease 2019 (COVID-19) has spread to almost all nooks and corners of the world. Medications are being developed to target the spike,...

Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China

Study attempts to understand coronavirus disease 2019 (COVID-19) vaccine demand and hesitancy. The majority reported a probably yes intent (54.6%) fol...

A global survey of potential acceptance of a COVID-19 vaccine

Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. 71.5% of participants reported that they would be very or somewhat...

Coronavirus vaccine development: from SARS and MERS to COVID-19

SARS-CoV-2 is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19). It has been the most challenging pandemic in this century...

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020

Pfizer-BioNTech COVID-19 vaccine has reported 4,393 (0.2%) adverse events in the Cases of anaphylaxis were determined to be rare but still under inve...